Originally intended for life-saving salvage therapy, the use of temporary mechanical
circulatory support (MCS) devices has become increasingly widespread in a variety of …

Trials on intra-aortic balloon pump (IABP) use in cardiogenic shock related to acute
myocardial infarction have shown disappointing results. The role of IABP in cardiogenic …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …

Background. In October 2018, a new heart allocation policy was implemented with intent of
prioritizing the sickest patients and decreasing waitlist time. We examined the effects of the …

Congestive heart failure (CHF) is a debilitating condition that afflicts tens of millions of
people worldwide and is responsible for more deaths each year than all cancers combined …

Preclinical large animal models of heart failure (HF) play a critical and expanding role in
translating basic science findings to the development and clinical approval of novel …

Aims Patients suffering from cardiogenic shock (CS) have a high mortality and morbidity.
The Impella percutaneous left-ventricular assist device (LVAD) decreases LV preload …

Cardiogenic shock is a critical condition of low cardiac output resulting in insufficient
systemic perfusion and end-organ dysfunction. Though significant advances have been …

Background: The use of the intra-aortic balloon pump (IABP) as a support device remains
controversial due to the fact that a number of studies have shown no benefit in end mortality …

Acute mechanical circulatory support (MCS) devices are widely used in cardiogenic shock
(CS) despite a lack of high-quality clinical evidence to guide their use. Multiple devices exist …